Connection

GIULIO DRAETTA to Animals

This is a "connection" page, showing publications GIULIO DRAETTA has written about Animals.
Connection Strength

0.485
  1. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019 04; 568(7752):410-414.
    View in: PubMed
    Score: 0.029
  2. In?Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Cell Rep. 2016 06 28; 16(1):133-147.
    View in: PubMed
    Score: 0.024
  3. Sugar? No Thank You, Just a Deep Breath of Oxygen for Cancer Stem Cells. Cell Metab. 2015 Oct 06; 22(4):543-5.
    View in: PubMed
    Score: 0.022
  4. Tumors and mitochondrial respiration: a neglected connection. Cancer Res. 2015 Sep 15; 75(18):3685-6.
    View in: PubMed
    Score: 0.022
  5. Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer. Cancer Res. 2015 Mar 15; 75(6):1091-101.
    View in: PubMed
    Score: 0.022
  6. Cancer drug discovery faces the FACT. Sci Transl Med. 2011 Aug 10; 3(95):95ps34.
    View in: PubMed
    Score: 0.017
  7. EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes. Oncogene. 2004 May 27; 23(25):4454-65.
    View in: PubMed
    Score: 0.010
  8. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep. 2003 Jul; 4(7):671-7.
    View in: PubMed
    Score: 0.010
  9. SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proc Natl Acad Sci U S A. 2023 05 23; 120(21):e2209639120.
    View in: PubMed
    Score: 0.010
  10. Immune landscape of a genetically engineered murine model of glioma compared with human glioma. JCI Insight. 2022 06 22; 7(12).
    View in: PubMed
    Score: 0.009
  11. PGC1a/? Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer. Cancer Res. 2022 04 01; 82(7):1423-1434.
    View in: PubMed
    Score: 0.009
  12. Discovery of 6-[(3S,4S)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 Inhibitor. J Med Chem. 2021 10 28; 64(20):15141-15169.
    View in: PubMed
    Score: 0.009
  13. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis. Science. 2021 Sep 17; 373(6561):eabj0486.
    View in: PubMed
    Score: 0.008
  14. Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancer Res. 2021 11 01; 81(21):5572-5581.
    View in: PubMed
    Score: 0.008
  15. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat Commun. 2021 07 30; 12(1):4626.
    View in: PubMed
    Score: 0.008
  16. Targeting the av integrin/TGF-? axis improves natural killer cell function against glioblastoma stem cells. J Clin Invest. 2021 07 15; 131(14).
    View in: PubMed
    Score: 0.008
  17. Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer. Gastroenterology. 2021 07; 161(1):196-210.
    View in: PubMed
    Score: 0.008
  18. Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress. Cancer Res. 2021 01 15; 81(2):332-343.
    View in: PubMed
    Score: 0.008
  19. Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties. J Med Chem. 2020 11 12; 63(21):12957-12977.
    View in: PubMed
    Score: 0.008
  20. Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib. Cancer Res. 2020 11 01; 80(21):4840-4853.
    View in: PubMed
    Score: 0.008
  21. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells. J Exp Med. 2020 08 03; 217(8).
    View in: PubMed
    Score: 0.008
  22. Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma. Cancer Res. 2019 Nov 01; 79(21):5612-5625.
    View in: PubMed
    Score: 0.007
  23. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med. 2019 05 08; 11(491).
    View in: PubMed
    Score: 0.007
  24. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors. Cancer Cell. 2019 02 11; 35(2):204-220.e9.
    View in: PubMed
    Score: 0.007
  25. Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors. Cell Rep. 2019 02 05; 26(6):1518-1532.e9.
    View in: PubMed
    Score: 0.007
  26. Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation. Cell Rep. 2019 01 08; 26(2):469-482.e5.
    View in: PubMed
    Score: 0.007
  27. High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun. 2018 11 29; 9(1):5079.
    View in: PubMed
    Score: 0.007
  28. UBPY: a growth-regulated human ubiquitin isopeptidase. EMBO J. 1998 Jun 15; 17(12):3241-50.
    View in: PubMed
    Score: 0.007
  29. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018 07; 24(7):1036-1046.
    View in: PubMed
    Score: 0.007
  30. 11th European Cell Cycle Conference: April 23-26, 1997, Gardone Riviera (Italy) and Symposium on Cell Cycle Regulation (17th International Congress of Biochemistry and Molecular Biology): August 24-29, 1997, San Francisco, CA. Biochim Biophys Acta. 1998 Feb 20; 1377(1):R11-20.
    View in: PubMed
    Score: 0.007
  31. EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming. Cancer Res. 2017 12 01; 77(23):6651-6666.
    View in: PubMed
    Score: 0.006
  32. PRKCI promotes immune suppression in ovarian cancer. Genes Dev. 2017 06 01; 31(11):1109-1121.
    View in: PubMed
    Score: 0.006
  33. Cdc25 protein phosphatases in cell proliferation. Biochim Biophys Acta. 1997 Apr 18; 1332(2):M53-63.
    View in: PubMed
    Score: 0.006
  34. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Nature. 2017 02 16; 542(7641):362-366.
    View in: PubMed
    Score: 0.006
  35. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature. 2017 02 02; 542(7639):119-123.
    View in: PubMed
    Score: 0.006
  36. In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype. Cancer Discov. 2016 06; 6(6):650-63.
    View in: PubMed
    Score: 0.006
  37. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor. J Med Chem. 2016 Feb 25; 59(4):1440-54.
    View in: PubMed
    Score: 0.006
  38. Mammalian G1 cyclins. Curr Opin Cell Biol. 1994 Dec; 6(6):842-6.
    View in: PubMed
    Score: 0.005
  39. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014 Oct 30; 514(7524):628-32.
    View in: PubMed
    Score: 0.005
  40. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell. 2014 Jul 03; 158(1):185-197.
    View in: PubMed
    Score: 0.005
  41. The Schizosaccharomyces pombe casein kinase II alpha and beta subunits: evolutionary conservation and positive role of the beta subunit. Mol Cell Biol. 1994 Jan; 14(1):576-86.
    View in: PubMed
    Score: 0.005
  42. Molecular pathology of the cell cycle in human cancer cells. Stem Cells. 1993 May; 11 Suppl 1:51-8.
    View in: PubMed
    Score: 0.005
  43. Phosphorylation and activation of human cdc25-C by cdc2--cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J. 1993 Jan; 12(1):53-63.
    View in: PubMed
    Score: 0.005
  44. Distinct forms of human CDC2 identified by novel monoclonal antibodies. Eur J Biochem. 1992 Jul 01; 207(1):169-76.
    View in: PubMed
    Score: 0.004
  45. PDK1 attenuation fails to prevent tumor formation in PTEN-deficient transgenic mouse models. Cancer Res. 2011 Apr 15; 71(8):3052-65.
    View in: PubMed
    Score: 0.004
  46. Cyclin A, cell cycle control and oncogenesis. Prog Growth Factor Res. 1991; 3(4):267-77.
    View in: PubMed
    Score: 0.004
  47. Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. Trends Biochem Sci. 1990 Oct; 15(10):378-83.
    View in: PubMed
    Score: 0.004
  48. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Cancer Res. 2010 Mar 15; 70(6):2476-84.
    View in: PubMed
    Score: 0.004
  49. Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia. Br J Pharmacol. 2009 Nov; 158(5):1183-95.
    View in: PubMed
    Score: 0.004
  50. Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell. 1989 Mar 10; 56(5):829-38.
    View in: PubMed
    Score: 0.004
  51. The mammalian cdc2 protein kinase: mechanisms of regulation during the cell cycle. J Cell Sci Suppl. 1989; 12:21-7.
    View in: PubMed
    Score: 0.004
  52. The phosphorylation of calmodulin and calmodulin fragments by kinase fractions from bovine brain. Biochim Biophys Acta. 1988 Oct 28; 972(1):69-78.
    View in: PubMed
    Score: 0.003
  53. Synthesis of p34, the mammalian homolog of the yeast cdc2+/CDC28 protein kinase, is stimulated during adenovirus-induced proliferation of primary baby rat kidney cells. Oncogene. 1988 Jun; 2(6):553-7.
    View in: PubMed
    Score: 0.003
  54. Purification of calmodulin-stimulated phosphodiesterase by affinity chromatography on calmodulin fragment 1-77 linked to sepharose. Methods Enzymol. 1988; 159:573-81.
    View in: PubMed
    Score: 0.003
  55. Regulation of the vertebrate cell cycle by the cdc2 protein kinase. Cold Spring Harb Symp Quant Biol. 1988; 53 Pt 1:195-201.
    View in: PubMed
    Score: 0.003
  56. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science. 2007 May 11; 316(5826):900-4.
    View in: PubMed
    Score: 0.003
  57. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol Cell Biol. 2005 Apr; 25(8):3338-47.
    View in: PubMed
    Score: 0.003
  58. The effects of lidocaine and procainamide on the sarcolemmal membrane high affinity cyclic AMP phosphodiesterase of rat myocardium. Gen Pharmacol. 1985; 16(2):115-9.
    View in: PubMed
    Score: 0.003
  59. Characterization of the BUD31 gene of Saccharomyces cerevisiae. Biochem Biophys Res Commun. 2004 Aug 06; 320(4):1342-50.
    View in: PubMed
    Score: 0.003
  60. Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene. 2004 Mar 15; 23(11):2050-6.
    View in: PubMed
    Score: 0.003
  61. The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1. EMBO Rep. 2002 Nov; 3(11):1062-8.
    View in: PubMed
    Score: 0.002
  62. Histone deacetylase 1 inactivation by an adenovirus early gene product. Curr Biol. 2002 Apr 02; 12(7):594-8.
    View in: PubMed
    Score: 0.002
  63. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 2001 Dec 03; 20(23):6672-82.
    View in: PubMed
    Score: 0.002
  64. [Experimental research on the toxicity of PVC administered orally]. Boll Soc Ital Biol Sper. 1981 Apr 30; 57(8):926-8.
    View in: PubMed
    Score: 0.002
  65. Interaction between Cdc37 and Cdk4 in human cells. Oncogene. 1997 Apr 24; 14(16):1999-2004.
    View in: PubMed
    Score: 0.002
  66. CDC25 phosphatases as potential human oncogenes. Science. 1995 Sep 15; 269(5230):1575-7.
    View in: PubMed
    Score: 0.001
  67. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995 Aug 04; 269(5224):682-5.
    View in: PubMed
    Score: 0.001
  68. Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci U S A. 1993 Apr 15; 90(8):3685-9.
    View in: PubMed
    Score: 0.001
  69. Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts. Mol Biol Cell. 1993 Apr; 4(4):397-411.
    View in: PubMed
    Score: 0.001
  70. Regulation of the microtubule nucleating activity of centrosomes in Xenopus egg extracts: role of cyclin A-associated protein kinase. J Cell Biol. 1992 Mar; 116(6):1431-42.
    View in: PubMed
    Score: 0.001
  71. cdc2 phosphorylation is required for its interaction with cyclin. EMBO J. 1991 Nov; 10(11):3311-9.
    View in: PubMed
    Score: 0.001
  72. E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol Cell Biol. 1991 Aug; 11(8):4253-65.
    View in: PubMed
    Score: 0.001
  73. A cdc2-like kinase phosphorylates histone H1 in the amitotic macronucleus of Tetrahymena. EMBO J. 1991 Aug; 10(8):2069-75.
    View in: PubMed
    Score: 0.001
  74. Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol. 1991 Mar; 11(3):1185-94.
    View in: PubMed
    Score: 0.001
  75. Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies activation during entry into mitosis. Cell. 1989 Jul 14; 58(1):193-203.
    View in: PubMed
    Score: 0.001
  76. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell. 1989 May 05; 57(3):393-401.
    View in: PubMed
    Score: 0.001
  77. Inhibition of adenylate cyclase by transglutaminase-catalyzed reactions in pigeon erythrocyte ghosts. Biochem Biophys Res Commun. 1986 Jul 31; 138(2):596-603.
    View in: PubMed
    Score: 0.001
  78. Genetically engineered calmodulins differentially activate target enzymes. J Biol Chem. 1986 Jul 25; 261(21):9896-903.
    View in: PubMed
    Score: 0.001
  79. Do porins inhibit the macrophage phagocyting activity by stimulating the adenylate cyclase? J Cyclic Nucleotide Protein Phosphor Res. 1986; 11(2):87-97.
    View in: PubMed
    Score: 0.001
  80. Different modes of interaction of calmodulin with its target enzymes. J Cardiovasc Pharmacol. 1986; 8 Suppl 8:S52-6.
    View in: PubMed
    Score: 0.001
  81. The stereomorphologic disposition of the muscular capillary network. Experimental research into the effect of training, age, arterial insufficiency and chronic treatment with EPL. J Sports Med Phys Fitness. 1984 Mar; 24(1):1-12.
    View in: PubMed
    Score: 0.001
  82. Relationship between the fluidity of the membrane lipids and the activity of the membrane-bound proteins: the effects of lidocaine on the adenylate cyclase activity of rat myocardium. Gen Pharmacol. 1983; 14(6):669-72.
    View in: PubMed
    Score: 0.001
  83. Endotoxin inhibits the fluoride-stimulated adenylate cyclase activity of rat liver membranes enriched with bile canaliculi. Experientia. 1982 Jul 15; 38(7):831-3.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.